{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:39:59Z","timestamp":1767148799108,"version":"build-2238731810"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T00:00:00Z","timestamp":1546560000000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.xkme.2018.12.003","type":"journal-article","created":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T01:06:23Z","timestamp":1550624783000},"page":"31-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Use of Repository Corticotropin Gel (Acthar) in\u00a0Progressive Nephrotic Syndrome Secondary to Transplant Glomerulopathy: A Report of Three Cases"],"prefix":"10.1016","volume":"1","author":[{"given":"Mariana","family":"Markell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amarpali","family":"Brar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Bhela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankita","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moro","family":"Salifu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xkme.2018.12.003_bib1","first-page":"S104","article-title":"A\u00a0specific glomerular lesion of the graft: allograft glomerulopathy","volume":"42","author":"Habib","year":"1993","journal-title":"Kidney Int Suppl"},{"issue":"12","key":"10.1016\/j.xkme.2018.12.003_bib2","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1111\/j.1600-6143.2007.01995.x","article-title":"Transplant glomerulopathy: ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies","volume":"7","author":"Wavamunno","year":"2007","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.xkme.2018.12.003_bib3","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/ki.1985.83","article-title":"Transplant glomerulopathy: evolution of morphologically distinct changes","volume":"27","author":"Maryniak","year":"1985","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.xkme.2018.12.003_bib4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1600-6143.2007.02104.x","article-title":"Transplant glomerulopathy","volume":"8","author":"Cosio","year":"2008","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.xkme.2018.12.003_bib5","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/j.1600-6143.2007.01836.x","article-title":"Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause","volume":"7","author":"Sis","year":"2007","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.xkme.2018.12.003_bib6","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1681\/ASN.2014030287","article-title":"The two kidney to one kidney transition and transplant glomerulopathy: a podocyte perspective","volume":"26","author":"Yang","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.xkme.2018.12.003_bib7","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/ndt\/gfu069","article-title":"A\u00a0pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar(R) Gel) in nephrotic syndrome due to idiopathic membranous nephropathy","volume":"29","author":"Hladunewich","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.xkme.2018.12.003_bib8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nrneph.2011.190","article-title":"The renaissance of corticotropin therapy in proteinuric nephropathies","volume":"8","author":"Gong","year":"2011","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2018.12.003_bib9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/ckj\/sfw045","article-title":"Efficacy and safety of adrenocorticotropic hormone treatment in glomerular diseases: a systematic review and meta-analysis","volume":"9","author":"Kittanamongkolchai","year":"2016","journal-title":"Clin Kidney J"},{"issue":"8","key":"10.1016\/j.xkme.2018.12.003_bib10","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1681\/ASN.2009101025","article-title":"Melanocortin 1 receptor agonists reduce proteinuria","volume":"21","author":"Lindskog","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2018.12.003_bib11","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/ndt\/gfh110","article-title":"ACTH-induced improvement in the nephrotic syndrome in patients with a variety of diagnoses","volume":"19","author":"Berg","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.xkme.2018.12.003_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/j.ajkd.2005.10.016","article-title":"A\u00a0randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy","volume":"47","author":"Ponticelli","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.xkme.2018.12.003_bib13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/DDDT.S17521","article-title":"Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel","volume":"5","author":"Bomback","year":"2011","journal-title":"Drug Design Dev Ther"},{"issue":"12","key":"10.1016\/j.xkme.2018.12.003_bib14","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.2215\/CJN.02840313","article-title":"Treatment of idiopathic FSGS with adrenocorticotropic hormone gel","volume":"8","author":"Hogan","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2018.12.003_bib15","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1046\/j.1523-1755.1999.00675.x","article-title":"Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy","volume":"56","author":"Berg","year":"1999","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.xkme.2018.12.003_bib16","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1681\/ASN.2014090945","article-title":"Transplant glomerulopathy: the view from the other side of the basement membrane","volume":"26","author":"Haas","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.xkme.2018.12.003_bib17","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.ackd.2013.09.004","article-title":"Leveraging melanocortin pathways to treat glomerular diseases","volume":"21","author":"Gong","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.xkme.2018.12.003_bib18","doi-asserted-by":"crossref","first-page":"27589","DOI":"10.1038\/srep27589","article-title":"MC1R is dispensable for the proteinuria reducing and glomerular protective effect of melanocortin therapy","volume":"6","author":"Qiao","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.xkme.2018.12.003_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12882-016-0241-7","article-title":"Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series","volume":"17","author":"Madan","year":"2016","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.xkme.2018.12.003_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.regpep.2006.11.003","article-title":"Melanocortin-3 receptor activates MAP kinase via PI3 kinase","volume":"139","author":"Chai","year":"2007","journal-title":"Regul Peptides"},{"issue":"1","key":"10.1016\/j.xkme.2018.12.003_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.56.1.1","article-title":"Targeting melanocortin receptors as a novel strategy to control inflammation","volume":"56","author":"Catania","year":"2004","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.xkme.2018.12.003_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fmed.2015.00013","article-title":"A\u00a0case report of adrenocorticotropic hormone to treat recurrent focal segmental glomerular sclerosis post-transplantation and biomarker monitoring","volume":"2","author":"Anwar","year":"2015","journal-title":"Front Med"},{"issue":"suppl 3","key":"10.1016\/j.xkme.2018.12.003_bib23","first-page":"344","article-title":"Recurrence of FSGS post kidney transplantation: salvage therapy with ACTHAR (R) Gel","volume":"16","author":"Vaitla","year":"2016","journal-title":"Am J Transplant"},{"issue":"suppl 3","key":"10.1016\/j.xkme.2018.12.003_bib24","first-page":"566","article-title":"Treatment\u00a0of\u00a0post-transplant nephrotic syndrome with adrenocorticotropic (ACTH) gel","volume":"17","author":"Khalil","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.xkme.2018.12.003_bib25","first-page":"125","article-title":"Adrenocorticotropic hormone analog use for podocytopathies","volume":"9","author":"Filippone","year":"2016","journal-title":"Int Med Case Rep J"}],"updated-by":[{"DOI":"10.1016\/j.xkme.2019.12.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000}}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059519300093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059519300093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:18:15Z","timestamp":1762910295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059519300093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S2590059519300093"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2018.12.003","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Repository Corticotropin Gel (Acthar) in\u00a0Progressive Nephrotic Syndrome Secondary to Transplant Glomerulopathy: A Report of Three Cases","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2018.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc. on behalf of National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}